The significance of this finding lies in the way it connects two domains of plant biology that have often been studied in isolation: hormone signalling and central carbon metabolism. Brassinosteroids are perceived at the cell surface by receptor complexes that ultimately inactivate a protein kinase called BIN2, a glycogen synthase kinase 3-like enzyme that functions as a central negative regulator of the brassinosteroid pathway. When brassinosteroid levels are low, BIN2 is active and phosphorylates a suite of targets, including transcription factors of the BZR1 family, thereby suppressing growth-related gene expression. When hormone levels rise, BIN2 is inhibited, its targets escape phosphorylation, and growth programmes are unleashed. The new work shows that this logic extends far beyond transcriptional control, reaching directly into the enzymatic core of sugar production.

PCK occupies a fascinating position in plant metabolism. In many plants, particularly those using C4 photosynthesis such as maize and sorghum, phosphoenolpyruvate carboxykinase catalyses the decarboxylation of oxaloacetate to release carbon dioxide and regenerate phosphoenolpyruvate, a step that concentrates carbon around the photosynthetic enzyme Rubisco and dramatically improves efficiency in hot, sunny climates. In other contexts, PCK drives gluconeogenesis, the synthesis of sugars from organic acids and lipid-derived carbon, which is essential during germination when seedlings must convert stored fat into the sugars needed to fuel early growth. In Arabidopsis, a C3 plant, PCK1 contributes to gluconeogenesis and to photosynthetic carbon metabolism, making the enzyme a versatile node at the intersection of energy production and carbon allocation.

The trail leading to the new discovery began with earlier proteomic work. A study by Tang and colleagues published in 2008 used prefractionation and two-dimensional difference gel electrophoresis to catalogue proteins whose modification changed after brassinosteroid treatment, and it revealed that PCK1 underwent dephosphorylation in response to the hormone. At the time, the observation was intriguing but mechanistically unexplained: it was not known which kinase placed the phosphate on PCK1, whether that modification affected enzyme activity, or whether the change mattered physiologically. The new study closes those gaps by identifying BIN2 as the kinase responsible and by showing that the phosphorylation event is functionally inhibitory.

A decisive piece of evidence came from a 2023 mapping effort by Kim and colleagues, who used TurboID-mediated proximity labelling coupled with mass spectrometry and phosphoproteomics to chart the signalling network of BIN2. That approach, which genetically fuses a promiscuous biotin ligase to BIN2 so that nearby proteins are labelled and can be identified, flagged PCK1 as a candidate substrate of the kinase. The new Nature Plants study builds directly on that lead, confirming that BIN2 physically interacts with PCK1, phosphorylates it at specific residues, and that this phosphorylation dampens the enzyme’s catalytic output. When brassinosteroids accumulate and BIN2 is restrained, PCK1 retains its unphosphorylated, active state, and sugar synthesis accelerates.

The physiological consequences of this regulatory module were tested across a remarkable evolutionary span. In Arabidopsis, the researchers manipulated brassinosteroid signalling and PCK1 phosphorylation status and observed corresponding changes in sugar accumulation. Strikingly, the same regulatory relationship held in maize and sorghum, two C4 grasses of enormous agricultural importance. The conservation of the BIN2–PCK1 module across such divergent species suggests that the coupling of brassinosteroid signalling to carbon metabolism is an ancient and fundamental feature of plant physiology rather than a quirk of a single lineage. For crop scientists, that conservation is encouraging news, because it implies that a single regulatory principle might be exploited to improve yield across cereals broadly.

The discovery also reframes a long-standing puzzle about how plants balance growth with carbon availability. Building new tissue requires both hormonal growth signals and an adequate supply of sugars, so plants need mechanisms that keep these two inputs in register. Recent work has shown that this coordination runs in both directions. In 2021, Zhang and colleagues reported that high sugar levels under light conditions can actually inhibit brassinosteroid signalling by enhancing BIN2-mediated phosphorylation of BZR1, providing a brake that prevents runaway growth when carbon status is already high. Conversely, the target of rapamycin pathway, a conserved nutrient-sensing network, promotes the accumulation of BZR1 in response to sugar, as shown in a 2016 study, thereby ensuring that sugar availability feeds positively into brassinosteroid signalling output.

Starvation adds a further layer of control. A 2025 study by Zhang and colleagues demonstrated that the ubiquitin ligase UPL3 mediates the degradation of BZR1 when nutrients run low, driving growth arrest and improving seedling survival under starvation stress. Taken together with the new findings, a coherent picture emerges: brassinosteroid signalling sits at the hub of a bidirectional dialogue with carbon metabolism, promoting sugar synthesis through PCK1 when conditions favour growth, while being restrained by sugar feedback and dismantled when carbon becomes scarce. The BIN2 kinase emerges as a shared bottleneck in this dialogue, phosphorylating both transcriptional regulators and metabolic enzymes to enforce the plant’s overall growth-versus-survival decision.

From a biotechnological standpoint, the implications are considerable. Enhancing PCK activity or reducing its inhibitory phosphorylation could, in principle, increase the efficiency with which crops convert carbon dioxide into sugars, the raw material for grain, biomass, and ultimately yield. Because the module operates in maize and sorghum, engineering or breeding strategies that favour the dephosphorylated, active state of PCK could be pursued in crops where even modest gains in photosynthetic efficiency translate into substantial harvest improvements. The finding also offers a mechanistic explanation for why brassinosteroid-related traits, such as enhanced seedling vigour, often correlate with improved performance in the field: the hormone is not merely stretching cells but also feeding the metabolic engine that powers growth.

As with any major advance, questions remain. The precise kinetic consequences of PCK1 phosphorylation at each target residue, the relative contributions of gluconeogenesis versus photosynthetic carbon concentration to the observed sugar increases, and the tissue-specific architecture of the BIN2–PCK1 module in developing seeds and leaves are all ripe for further study. It will also be important to determine whether tuning the module carries trade-offs, since unchecked sugar production could alter source–sink relationships within the plant. Nevertheless, by identifying a direct biochemical link between a growth hormone and a sugar-synthesising enzyme, the study transforms our understanding of how plants coordinate the decision to grow with the metabolic capacity to sustain it, and it hands crop engineers a concrete molecular target in the quest for more productive plants.

Subject of Research: Brassinosteroid hormone regulation of sugar synthesis through BIN2-mediated phosphorylation of phosphoenolpyruvate carboxykinase in plants

Article Title: Brassinosteroids boost sugar production by inhibiting PCK phosphorylation

Article References: Brassinosteroids boost sugar production by inhibiting PCK phosphorylation. (2026). Nature Plants, 12(9), 1673-1674. https://doi.org/10.1038/s41477-026-02378-6

Image Credits: AI Generated

DOI: 10.1038/s41477-026-02378-6

Keywords: brassinosteroids, BIN2 kinase, PCK, phosphorylation, sugar synthesis, gluconeogenesis, C4 photosynthesis, Arabidopsis thaliana, maize, sorghum, plant signalling, carbon metabolism

The study, led by researchers at Fujita Health University, set out to probe a long-standing puzzle in metabolic physiology. Insulin and glucagon, the two pancreatic hormones that jointly govern nutrient handling, respond very differently to protein than to carbohydrate. Glucose ingestion robustly stimulates insulin and suppresses glucagon in healthy individuals, but in type 2 diabetes the early insulin response is blunted and glucagon paradoxically rises. Protein, by contrast, stimulates both hormones in everyone, making protein a particularly potent glucagon secretagogue regardless of glycemic status. Because insulin drives amino acid uptake into peripheral tissues for protein synthesis while glucagon promotes hepatic gluconeogenesis, converting amino acids into glucose, the researchers hypothesized that the balance between these hormones, known as the insulin-to-glucagon ratio, would determine how the liver handles a sudden flood of dietary amino acids.

To test this, the team compared nondiabetic mice with mice made diabetic by injections of streptozotocin, a compound that destroys insulin-producing beta cells and produces a model of severe insulin deficiency. After an overnight fast, both groups received either a liquid normal control diet, containing roughly 67 percent carbohydrate and 15 percent protein, or a liquid high-protein diet with 58 percent protein and only 23 percent carbohydrate, matched for calories. Blood and liver samples were collected two hours after feeding, a window chosen to capture the immediate postprandial response rather than the slower transcriptional adaptation that emerges over days of high-protein feeding.

The hormonal results were revealing. In nondiabetic mice, the high-protein meal produced lower insulin and GIP secretion at 60 minutes than the control diet, an effect the authors attribute largely to the reduced carbohydrate content of the meal. Glucagon, however, rose significantly higher with the protein load. In diabetic mice, insulin secretion in response to the control diet was markedly attenuated, as expected, but the response to the high-protein diet was comparable to that of nondiabetic animals. Strikingly, despite lower insulin secretion, postprandial blood glucose was actually lower in diabetic mice given the high-protein meal than in those given the carbohydrate-rich control diet, suggesting that cutting carbohydrate from a meal can blunt glycemic excursions even when insulin secretion is impaired.

Plasma amino acid profiling then exposed a sharp divergence between the two metabolic states. The high-protein diet elevated nearly all essential amino acids, including the branched-chain amino acids leucine, isoleucine, and valine, in both diabetic and nondiabetic mice. But on the normal control diet, diabetic mice generally showed lower plasma amino acid levels than their nondiabetic counterparts, a pattern consistent with accelerated gluconeogenesis draining amino acids from the circulation. When the protein load arrived, several amino acids, including arginine, tyrosine, phenylalanine, tryptophan, and isoleucine, rose significantly higher in diabetic mice than in nondiabetic ones, hinting that the diabetic body handles a protein surge differently from the very first hours.

The liver told an even more dramatic story. In nondiabetic mice, two hours of high-protein feeding left hepatic amino acid content essentially unchanged, with glutamine the only significant increase. In diabetic mice, the same meal produced significant hepatic accumulation of alanine, aspartic acid, proline, threonine, and all three branched-chain amino acids, and the increase extended to nearly every essential amino acid except histidine. Glutamine was the lone exception, falling significantly below control levels. The combination of lower plasma levels for some amino acids and higher hepatic content in diabetic mice led the authors to conclude that amino acid uptake into the liver is accelerated in diabetic animals given a protein load, effectively overwhelming the organ’s metabolic capacity and leaving substrate pooled inside hepatic tissue.

Crucially, this accumulation occurred without any corresponding transcriptional program. Quantitative PCR of sixteen genes involved in glucose and amino acid metabolism, including gluconeogenic enzymes such as Pepck and G6pc, aminotransferases, urea cycle genes, and glutaminase, revealed almost no differences between diet groups within the two-hour window. The only significant diet-related change was Cps1 in diabetic mice. This stands in sharp contrast to the team’s earlier work showing that seven days of high-protein feeding induces robust glucagon-mediated upregulation of hepatic amino acid-catabolizing enzymes, which keeps plasma amino acids, apart from branched-chain amino acids, near normal. The new data indicate that the immediate postprandial amino acid excursion is governed by non-transcriptional mechanisms, such as altered tissue uptake and substrate diversion toward gluconeogenesis, rather than by rapid changes in enzyme gene expression.

Signaling analyses added further nuance. Western blotting of liver proteins showed that Akt phosphorylation, a readout of insulin signaling, was significantly reduced by the high-protein meal in diabetic mice, and reduced glycogen content followed the same pattern in both groups, likely reflecting the meal’s lower carbohydrate content. Yet phosphorylation of GSK3β, Akt’s downstream effector in glycogen synthesis, and of CREB, the glucagon-responsive transcription factor, were unchanged across all four groups, suggesting that the two-hour time point captures signaling dynamics whose temporal relationship to hormone levels is more complex than simple feed-forward regulation. The authors note that time-course studies will be needed to untangle these kinetics.

Metabolomics also uncovered a paradox in hepatic glycogen. Despite impaired insulin secretion and a glucagon-dominant hormonal profile, diabetic mice had higher liver glycogen than nondiabetic mice under both diets, echoing recent evidence that glucagon may contribute to postprandial glycogen repletion and that hyperglycemia itself, through sheer substrate availability, can drive glycogen accumulation even without insulin action. Meanwhile, diabetic livers showed elevated early glycolytic and gluconeogenic intermediates, including glucose 6-phosphate and fructose 6-phosphate, which the authors interpret not as inefficient metabolic flux, as reported in obese diabetic models, but as a distinct state in which overwhelming substrate availability from accumulated amino acids feeds into glucose production pathways.

The clinical implications are intriguing and carefully hedged. In type 1 diabetes, where insulin secretion is severely compromised, protein-rich meals can promote hyperglycemia by stimulating glucagon. But the present findings suggest that when residual insulin secretion is preserved, as in many cases of type 2 diabetes, high-protein, low-carbohydrate feeding enhances hepatic amino acid uptake and glucose production without raising postprandial blood glucose, because the limited carbohydrate content offsets the glucose-raising effect of glucagon-stimulated gluconeogenesis. The study also raises new questions about FGF21, a liver-derived hormone acutely lowered by the protein meal in nondiabetic mice, hinting that its secretion is rapidly tuned by dietary protein or insulin action. The authors acknowledge limitations, including the absence of fasting-baseline metabolomics, no direct measurement of glycogen turnover, and no assessment of intestinal nutrient absorption. Even so, the work delivers a memorable message: in diabetes, the liver’s first response to a protein feast is a silent traffic jam of amino acids, one that precedes and perhaps shapes the slower genetic adaptation that follows.

Subject of Research: Acute high-protein feeding and hepatic amino acid metabolism in diabetic versus nondiabetic mice

Article Title: Acute high‐protein feeding induces hepatic amino acid accumulation in diabetic male mice prior to transcriptional adaptation

Article References: Acute high‐protein feeding induces hepatic amino acid accumulation in diabetic male mice prior to transcriptional adaptation. (n.d.). https://doi.org/10.14814/phy2.71117

Image Credits: AI Generated

DOI: 10.14814/phy2.71117

Keywords: diabetes, glucagon, insulin, amino acids, liver metabolism, high-protein diet, branched-chain amino acids, gluconeogenesis, FGF21, metabolomics, streptozotocin, postprandial metabolism